Indoleamine 2,3-dioxygenase (IDO) has been proposed as a possible marker of activation of immunological pathways induced by IFN gamma, representing an immune escape mechanism of tumor cells, and a negative prognostic factor in advanced stage lung cancer [64,65,66]. This evidence concerns the gene IDO1 and neoplasm.